A detailed history of Whittier Trust CO Of Nevada Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 99,422 shares of ABBV stock, worth $17.5 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
99,422
Previous 100,263 0.84%
Holding current value
$17.5 Million
Previous $17.2 Million 14.17%
% of portfolio
0.51%
Previous 0.48%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $137,789 - $167,636
-841 Reduced 0.84%
99,422 $19.6 Million
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $15,324 - $17,895
99 Added 0.1%
100,263 $17.2 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $5.21 Million - $5.94 Million
32,593 Added 48.24%
100,164 $18.2 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $237,360 - $267,323
-1,725 Reduced 2.49%
67,571 $10.5 Million
Q3 2023

Oct 27, 2023

SELL
$133.59 - $154.65 $237,790 - $275,277
-1,780 Reduced 2.5%
69,296 $10.3 Million
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $69,567 - $86,572
-525 Reduced 0.73%
71,076 $9.58 Million
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $107,156 - $123,406
741 Added 1.05%
71,601 $11.4 Million
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $11,064 - $13,269
-80 Reduced 0.11%
70,860 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $135,954 - $155,931
1,013 Added 1.45%
70,940 $9.52 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $167,070 - $212,401
-1,214 Reduced 1.71%
69,927 $10.7 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $597,737 - $741,623
4,529 Added 6.8%
71,141 $11.5 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $55,219 - $69,868
514 Added 0.78%
66,612 $9.02 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $20,960 - $23,793
197 Added 0.3%
66,098 $7.13 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $27,985 - $31,177
-266 Reduced 0.4%
65,901 $7.42 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $331,656 - $365,114
3,242 Added 5.15%
66,167 $7.16 Million
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $36,140 - $48,792
-449 Reduced 0.71%
62,925 $6.74 Million
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $35,480 - $41,642
-413 Reduced 0.65%
63,374 $5.55 Million
Q2 2020

Jul 10, 2020

BUY
$73.37 - $98.18 $119,079 - $159,346
1,623 Added 2.61%
63,787 $6.26 Million
Q1 2020

Apr 27, 2020

SELL
$64.5 - $97.79 $47,923 - $72,657
-743 Reduced 1.18%
62,164 $4.74 Million
Q4 2019

Jan 31, 2020

SELL
$72.13 - $90.25 $1.36 Million - $1.71 Million
-18,892 Reduced 23.1%
62,907 $5.57 Million
Q3 2019

Oct 18, 2019

SELL
$62.98 - $75.72 $755 - $908
-12 Reduced 0.01%
81,799 $6.19 Million
Q2 2019

Jul 23, 2019

SELL
$65.7 - $83.98 $79,628 - $101,783
-1,212 Reduced 1.46%
81,811 $5.95 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $913,646 - $1.08 Million
-11,844 Reduced 12.48%
83,023 $6.69 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $171,347 - $211,318
-2,201 Reduced 2.27%
94,867 $8.75 Million
Q3 2018

Oct 23, 2018

SELL
$88.91 - $98.84 $74,506 - $82,827
-838 Reduced 0.86%
97,068 $9.18 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $820,230 - $970,517
9,136 Added 10.29%
97,906 $9.07 Million
Q2 2018

Jul 20, 2018

SELL
$89.78 - $106.23 $823,821 - $974,766
-9,176 Reduced 9.37%
88,770 $5.01 Million
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $596,040 - $798,154
6,478 Added 7.08%
97,946 $9.27 Million
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $712,897 - $781,751
7,960 Added 9.53%
91,468 $8.85 Million
Q3 2017

Oct 23, 2017

BUY
$69.85 - $89.22 $5.83 Million - $7.45 Million
83,508
83,508 $7.42 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.